FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

1153502002: Product containing precisely darbepoetin alfa 40 microgram/1 milliliter conventional release solution for injection (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Jul 2024. Module: IPS terminology module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
4564578010 Darbepoetin alfa 40 microgram/mL solution for injection en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) IPS terminology module (core metadata concept)
4564579019 Product containing precisely darbepoetin alfa 40 microgram/1 milliliter conventional release solution for injection (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) IPS terminology module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Darbepoetin alfa 40 microgram/mL solution for injection Is a Product containing only darbepoetin alfa (medicinal product) true Inferred relationship Some
Darbepoetin alfa 40 microgram/mL solution for injection Has manufactured dose form Solution for injection true Inferred relationship Some
Darbepoetin alfa 40 microgram/mL solution for injection Has basis of strength substance (attribute) Darbepoetin alfa true Inferred relationship Some 1
Darbepoetin alfa 40 microgram/mL solution for injection Has concentration strength denominator unit mL true Inferred relationship Some 1
Darbepoetin alfa 40 microgram/mL solution for injection Has concentration strength numerator unit mcg true Inferred relationship Some 1
Darbepoetin alfa 40 microgram/mL solution for injection Has precise active ingredient Darbepoetin alfa true Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

International Patient Summary

Back to Start